1. Home
  2. KNSA vs JAMF Comparison

KNSA vs JAMF Comparison

Compare KNSA & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • JAMF
  • Stock Information
  • Founded
  • KNSA 2015
  • JAMF 2002
  • Country
  • KNSA United Kingdom
  • JAMF United States
  • Employees
  • KNSA N/A
  • JAMF N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • JAMF Computer Software: Prepackaged Software
  • Sector
  • KNSA Health Care
  • JAMF Technology
  • Exchange
  • KNSA Nasdaq
  • JAMF Nasdaq
  • Market Cap
  • KNSA 1.7B
  • JAMF 1.9B
  • IPO Year
  • KNSA 2018
  • JAMF 2020
  • Fundamental
  • Price
  • KNSA $21.09
  • JAMF $14.36
  • Analyst Decision
  • KNSA Strong Buy
  • JAMF Buy
  • Analyst Count
  • KNSA 5
  • JAMF 7
  • Target Price
  • KNSA $36.60
  • JAMF $23.00
  • AVG Volume (30 Days)
  • KNSA 365.7K
  • JAMF 536.0K
  • Earning Date
  • KNSA 10-29-2024
  • JAMF 11-07-2024
  • Dividend Yield
  • KNSA N/A
  • JAMF N/A
  • EPS Growth
  • KNSA N/A
  • JAMF N/A
  • EPS
  • KNSA N/A
  • JAMF N/A
  • Revenue
  • KNSA $384,098,000.00
  • JAMF $615,070,000.00
  • Revenue This Year
  • KNSA $60.05
  • JAMF $13.65
  • Revenue Next Year
  • KNSA $36.32
  • JAMF $12.96
  • P/E Ratio
  • KNSA N/A
  • JAMF N/A
  • Revenue Growth
  • KNSA 54.41
  • JAMF 13.85
  • 52 Week Low
  • KNSA $15.52
  • JAMF $14.02
  • 52 Week High
  • KNSA $28.15
  • JAMF $21.41
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 34.36
  • JAMF 29.59
  • Support Level
  • KNSA $20.41
  • JAMF $16.48
  • Resistance Level
  • KNSA $21.55
  • JAMF $14.83
  • Average True Range (ATR)
  • KNSA 0.87
  • JAMF 0.67
  • MACD
  • KNSA -0.14
  • JAMF -0.20
  • Stochastic Oscillator
  • KNSA 21.90
  • JAMF 8.54

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

Share on Social Networks: